Bristol Myers Squibb · Operating Cash Flow (Statement)

Latest reported$12.78Bperiod endingJun 30, 2026

BMY Cash from Operations ($1.19B → $12.78B)

Annual operating cash flow (statement)

High-resolution chart · PNG

BMY operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	14,156,000,000
Dec 31, 2024	15,190,000,000
Dec 31, 2023	13,860,000,000
Dec 31, 2022	13,066,000,000
Dec 31, 2021	16,207,000,000
Dec 31, 2020	14,052,000,000
Dec 31, 2019	8,210,000,000
Dec 31, 2018	7,066,000,000
Dec 31, 2017	5,275,000,000
Dec 31, 2016	3,058,000,000
Dec 31, 2015	2,105,000,000
Dec 31, 2014	3,148,000,000
Dec 31, 2013	3,545,000,000
Dec 31, 2012	6,941,000,000
Dec 31, 2011	4,840,000,000
Dec 31, 2010	4,491,000,000
Dec 31, 2009	4,065,000,000
Dec 31, 2008	3,707,000,000
Dec 31, 2007	3,153,000,000
Dec 31, 2006	2,083,000,000
Dec 31, 2005	1,836,000,000
Dec 31, 2004	3,176,000,000
Dec 31, 2003	3,512,000,000
Dec 31, 2002	945,000,000
Dec 31, 2001	5,402,000,000
Dec 31, 2000	4,652,000,000
Dec 31, 1999	4,224,000,000
Dec 31, 1998	3,782,000,000
Dec 31, 1997	2,476,000,000
Dec 31, 1996	2,641,000,000
Dec 31, 1995	2,499,000,000
Dec 31, 1994	2,301,000,000
Dec 31, 1993	2,580,000,000
Dec 31, 1992	2,028,000,000
Dec 31, 1991	1,835,000,000
Dec 31, 1990	1,752,000,000
Dec 31, 1989	1,190,000,000